Racial/ethnic differences in clinical trial enrollment, refusal rates, ineligibility, and reasons for decline among patients at sites in the National Cancer Institute's Community Cancer Centers Program

Cancer

Volumn 120, Issue 6, 2014, Pages 877-884

  Langford, Aisha T ^a   Resnicow, Ken ^a   Dimond, Eileen P ^b   Denicoff, Andrea M ^b   Germain, Diane St ^b   McCaskill Stevens, Worta ^b   Enos, Rebecca A ^c   Carrigan, Angela ^d   Wilkinson, Kathy ^e   Go, Ronald S ^f  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c EMMES CORPORATION   (United States)

^d SAIC FREDERICK INC   (United States)

^e Department of Hematology/Oncology   (United States)

^f GUNDERSEN HEALTH SYSTEM   (United States)

Author keywords

African Americans; cancer; clinical trials; Hispanic; medical research; minorities; racial ethnic

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL TRIAL (TOPIC); COLORECTAL CANCER; ETHNIC DIFFERENCE; FEMALE; HUMAN; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; REFUSAL TO PARTICIPATE; SCORING SYSTEM; UROGENITAL TRACT CANCER;

AFRICAN AMERICANS; CANCER; CLINICAL TRIALS; HISPANIC; MEDICAL RESEARCH; MINORITIES; RACIAL/ETHNIC;

AFRICAN AMERICANS; AGED; BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; NATIONAL CANCER INSTITUTE (U.S.); NEOPLASMS; PATIENT COMPLIANCE; PATIENT SELECTION; SURVIVAL RATE; UNITED STATES;

EID: 84896731433     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28483     Document Type: Article

References (27)

1. American Cancer Society. Economic Impact of Cancer. http://www.cancer. org/cancer/cancerbasics/economic-impact-of-cancer. Accessed April 15, 2013.
2. National Cancer Institute. SEER Stat Fact Sheets: All Sites. 2012; http://seer.cancer.gov/statfacts/html/all.html. Accessed April 9, 2013.
3. Institute of Medicine. A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program. National Academy of Sciences: Washington, DC; 2010.
4. Murthy VH, Krumholz HM, Gross CP,. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004; 291: 2720-2726. (Pubitemid 38725421)
5. National Cancer Institute. Fact Sheet: Cancer Health Disparities. 2012; http://www.cancer.gov/cancertopics/factsheet/disparities/cancer-health- disparities. Accessed May 10, 2013.
6. Ford JG, Howerton MW, Lai GY, et al. Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer. 2008; 112: 228-242.
7. Wendler D, Kington R, Madans J, et al. Are racial and ethnic minorities less willing to participate in health research? PLoS Med. 2006; 3 (2): e19.
8. Durant RW, Legedza AT, Marcantonio ER, Freeman MB, Landon BE,. Willingness to participate in clinical trials among African Americans and whites previously exposed to clinical research. J Cult Divers. 2011; 18: 8-19.
9. McCaskill-Stevens W, McKinney MM, Whitman CG, Minasian LM,. Increasing minority participation in cancer clinical trials: the minority-based community clinical oncology program experience. J Clin Oncol. 2005; 23: 5247-5254. (Pubitemid 46224036)
10. National Cancer Institute. NCI Community Cancer Centers Program. Progress Reports and Tools/Community Hospitals. 2013; http://ncccp.cancer.gov/about/ reports-and-tools.htm. Accessed April 10, 2013.
11. Grubbs SS, Go RS, Berger MZ, et al. Early success in narrowing age, gender, and racial disparities in clinical trial accrual: Targeted screening efforts through the National Cancer Institute Community Cancer Centers Program (NCCCP). J Clin Oncol. 2010; 29: (15 suppl): 6110.
12. Gonzalez M, Berger M, Brown T, et al. Using an Online Tool to Understand and Improve Clinical Trial Accruals. Oncol Issues. 2011; 26 (2): 50.
13. St. Germain D, Denicoff AM, Dimond EP, et al. Use of the National Cancer Institute Community Cancer Centers Program (NCCCP) screening and accrual log to address cancer clinical trial accrual. J Oncol Pract. 2013 (accepted).
14. Office of Management and Budget. Standards for the Classification of Federal Data on Race and Ethnicity. 2013; http://www.whitehouse.gov/omb/fedreg- race-ethnicity. Accessed April 15, 2013.
15. Brown H, Prescott R,. Applied Mixed Models in Medicine. New York, NY: John Wiley & Sons; 1999.
16. Micro Power & Light Co. Readability Formulas. 2013; http://www.micropowerandlight.com/rd.html. Accessed April 10, 2013.
17. Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D,. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA. 2005; 294: 1765-1772. (Pubitemid 41434622)
18. Adams-Campbell LL, Ahaghotu C, Gaskins M, et al. Enrollment of African Americans onto clinical treatment trials: study design barriers. J Clin Oncol. 2004; 22: 730-734. (Pubitemid 41095078)
19. Albrecht TL, Eggly SS, Gleason ME, et al. Influence of clinical communication on patients' decision making on participation in clinical trials. J Clin Oncol. 2008; 26: 2666-2673.
20. Schroen AT, Petroni GR, Wang H, et al. Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trials. Clin Trials. 2010; 7: 312-321.
21. Aapro MS, Kohne CH, Cohen HJ, Extermann M,. Never too old? Age should not be a barrier to enrollment in cancer clinical trials. Oncologist. 2005; 10: 198-204. (Pubitemid 40463157)
22. Baquet CR, Ellison GL, Mishra SI,. Analysis of Maryland Cancer Patient Participation in National Cancer Institute-Supported Cancer Treatment Clinical Trials. J Health Care Poor Underserved. 2009; 20 (2 suppl): 120-134.
23. Hurria A, Cirrincione CT, Muss HB, et al. Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. J Clin Oncol. 2011; 29: 1290-1296.
24. Coyne CA, Xu R, Raich P, et al. Randomized, controlled trial of an easy-to-read informed consent statement for clinical trial participation: a study of the Eastern Cooperative Oncology Group. J Clin Oncol. 2003; 21: 836-842. (Pubitemid 46606443)
25. Cheung WY, Pond GR, Heslegrave RJ, Enright K, Potanina L, Siu LL,. The contents and readability of informed consent forms for oncology clinical trials. Am J Clin Oncol. 2010; 33: 387-392.
26. National Cancer Institute. Simplification of Informed Consent Documents. 2013; http://www.cancer.gov/clinicaltrials/conducting/simplification-of- informed-consent-docs. Accessed July 17, 2013.
27. US Census Bureau. 2010 Census Briefs. Overview of Race and Hispanic Origin: 2010. http://www.census.gov/prod/cen2010/briefs/c2010br-02.pdf. Accessed July 16, 2013.